Premier Wine Tasting and Auction Brought Acclaimed Napa Valley Vintners Together with Miami Philanthropists to Benefit Global Nonprofit CureDuchenne MIAMI, FL, April 16, 2025 – CureDuchenne, a global nonprofit committed to […]
“Vintage Vegas for Duchenne” Gala Featured Casino Games, Cocktails, Gourmet Dining, and More to Help Advance Research for the Rare Disease AUSTIN, Texas., April 15, 2025 – CureDuchenne, a leading […]
Download PDF HERE CHAMPIONS SPONSORSHIP OPPORTUNITIES 2025
Wave Life Science Exon Skipping in Duchenne Wave Life Sciences: Update on 48-week Data from FORWARD-53 Exon Skipping Study: An update on Wave’s Phase 2 FORWARD-53 trial of WE-N531, Wave’s […]
Napa in Miami 2025 Auction Catalog Bid by proxy by emailing okairy@dev.cureduchenne.com
Duchenne muscular dystrophy (DMD) – An update on the DELIVER trial of DYNE-251 in males with DMD mutations amenable to exon 51 skipping. WATCH HERE
Wave Life Sciences Exon-skipping Trial Wave Life Sciences has shared new data from its ongoing FORWARD-53 clinical trial, evaluating the investigational exon-skipping therapy WVE-N531 for individuals with Duchenne muscular dystrophy […]
Entrada trial skipping exon 45 CureDuchenne provided early funding to Entrada Therapeutics, who has announced that they received authorization in the United Kingdom (UK) to initiate a Phase 1/2 multiple […]
